The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator

202225 citationsJournal Articlegold Open Access

Authors

Sneha Parekh · Icahn School of Medicine at Mount Sinai

Parita Ratnani · Icahn School of Medicine at Mount Sinai

Ugo Giovanni Falagario · Icahn School of Medicine at Mount Sinai

Dara Lundon · Icahn School of Medicine at Mount Sinai

Deepshikha Kewlani · Icahn School of Medicine at Mount Sinai

Jordan Nasri · Icahn School of Medicine at Mount Sinai

Zach Dovey

Abstract

We developed the Mount Sinai Prebiopsy Risk Calculator (MSP-RC) to assess the likelihood of any prostate cancer and clinically significant disease based on a combination of clinical and imaging characteristics. MSP-RC is applicable to all patient settings and accessible online.

Topics & Keywords

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Colorectal Cancer Screening and Detection

UN Sustainable Development Goals

Peace, Justice and strong institutions

Publication Details

Published in: European Urology Open Science

Volume 41, pp. 45-54

DOI: 10.1016/j.euros.2022.04.017

Field-Weighted Citation Impact: 3.80

Command Palette

Authors

Abstract

Topics & Keywords

UN Sustainable Development Goals

Publication Details